Atossa Therapeutics ATOS
NASDAQ ATOS
$2.14 +0.01 (+0.47%)
At close: Nov 10, 2026 · 4:00 PM EST

Atossa Therapeutics (ATOS) Non Operating Income (2014 - 2019)

Updated

Atossa Therapeutics (ATOS) reported Non Operating Income of $104.00 for Q3 2018, compared with -$283.00 a year earlier.

Analysis

Atossa Therapeutics (ATOS) Non Operating Income (2014 - 2019) Analysis & Trends

Over the twelve months ended Sep 30, 2018, Atossa Therapeutics' Non Operating Income came in at -$83.00; for FY2015, it came in at $431.00, up 65.8% from FY2014.

  • By year, Non Operating Income came in at $260.00 in FY2014.
  • The Q3 2018 figure ranks as the highest quarterly Non Operating Income since Q3 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -202.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.63 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -130.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Atossa Therapeutics 21.38 Mn -98.31 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 -8,978.00
Sep 30, 2018 104.00
Mar 31, 2018 59.00
Dec 31, 2017 362.00
Sep 30, 2017 -283.00
Mar 31, 2017 37.00
Dec 31, 2016 38.00
Sep 30, 2016 1.76 Mn
Dec 31, 2015 -115,677.00
Sep 30, 2015 69,350.00
Jun 30, 2015 48,659.00
Mar 31, 2015 -1,415.00
Dec 31, 2014 2,449.00
Sep 30, 2014 -140.00
Jun 30, 2014 -1,443.00
API Access

Atossa Therapeutics Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=ATOS&period=max&api_key=YOUR_API_KEY